|
Volumn 43, Issue 1, 1993, Pages 109-114
|
Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-β-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
BENZODIAZEPINE DERIVATIVE;
NEVIRAPINE;
PURINE NUCLEOSIDE DERIVATIVE;
PYRIDONE DERIVATIVE;
PYRIMIDINE NUCLEOSIDE DERIVATIVE;
RNA DIRECTED DNA POLYMERASE;
ANTIVIRAL ACTIVITY;
ARTICLE;
DRUG CLASSIFICATION;
DRUG MECHANISM;
DRUG RESISTANCE;
DRUG SELECTIVITY;
DRUG STRUCTURE;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
PRIORITY JOURNAL;
STRAIN DIFFERENCE;
VIRUS REPLICATION;
AMINO ACID SEQUENCE;
ANTIVIRAL AGENTS;
BASE SEQUENCE;
DRUG RESISTANCE;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
HUMAN;
HYPOXANTHINES;
MOLECULAR SEQUENCE DATA;
MUTATION;
RNA-DIRECTED DNA POLYMERASE;
SPIRO COMPOUNDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUPPORT, NON-U.S. GOV'T;
THYMIDINE;
|
EID: 0027524005
PISSN: 0026895X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (44)
|
References (0)
|